En la linguatuliasis nasofaríngea aguda —síndrome de Halzoun o Marrara—, la persona suele ingerir hígado, ganglios linfáticos, pulmones u otras vísceras crudas o insuficientemente cocidas que contienen ninfas infectantes de Linguatula serrata. Estas ninfas se liberan en la boca o el estómago, ascienden y se adhieren a la mucosa faríngea o nasofaríngea. No se multiplican allí. Cada parásito presente corresponde a un parásito que fue ingerido. (pmc.ncbi.nlm.nih.gov)

Por lo tanto:

Una vez que todas las ninfas adheridas han sido expulsadas o retiradas, la infestación nasofaríngea activa normalmente ha terminado.

En un caso publicado, el paciente quedó asintomático después de la extracción. En otro caso documentado, la enfermedad se resolvió espontáneamente aproximadamente diez días después de que comenzaran a aparecer ninfas en la secreción nasal. (pubmed.ncbi.nlm.nih.gov)

Por qué no existe una infección amplificadora

El hecho decisivo es que L. serrata tiene un ciclo de vida indirecto que requiere dos tipos de hospedador:

adulto en el hospedador definitivo→huevos→

tejidos del hospedador intermediario→ninfa→hospedador definitivo

En el ciclo normal:

1. Los parásitos adultos, machos y hembras, viven en las cavidades nasales de un perro u otro carnívoro.
2. Después de la reproducción sexual, la hembra libera huevos.
3. Los huevos salen del hospedador mediante las secreciones nasales o las heces.
4. Un herbívoro u otro hospedador intermediario ingiere los huevos.
5. Las larvas atraviesan el intestino y se desarrollan mediante varios estadios en los órganos internos y los ganglios linfáticos.
6. Un carnívoro come esos tejidos infectados.
7. Las ninfas maduras migran hacia la nasofaringe del carnívoro y finalmente se transforman en adultos.

No existe multiplicación asexual ni en los seres humanos ni en los hospedadores animales habituales. Una sola ninfa no puede dividirse, gemar ni producir nuevas ninfas. L. serrata tiene sexos separados, y la producción de huevos requiere maduración y reproducción sexual. (animaldiversity.org)

Por eso, una infección humana aguda no puede progresar como la estrongiloidiasis, en la cual las larvas pueden producir un ciclo interno de autoinfección. Tampoco se comporta como una infección por protozoos, en la cual un solo organismo puede multiplicarse hasta producir miles.

La salvedad importante: un parásito expulsado puede no ser el único

La afirmación «el parásito fue expulsado, por lo tanto la persona está curada» solo es válida cuando todos los parásitos han sido expulsados o retirados.

Un fragmento infectado de hígado o tejido linfático puede contener varias ninfas. En algunos casos humanos se documentó la expulsión sucesiva de varios parásitos mediante tos y estornudos. En un brote familiar, primero se retiraron ninfas de la lengua y posteriormente se expulsaron otros organismos. (pubmed.ncbi.nlm.nih.gov)

En consecuencia:

• La expulsión de una ninfa no demuestra que hubiera una sola.
• Pueden permanecer otras ninfas adheridas en la nariz, la nasofaringe, la región amigdalina, los orificios de las trompas de Eustaquio u otras áreas próximas de la mucosa.
• La persistencia de sensación de cuerpo extraño, tos, estornudos, sangrado, síntomas nasales unilaterales, molestias de oído o percepción recurrente de movimiento justifica una evaluación otorrinolaringológica, preferentemente mediante endoscopia nasal y nasofaríngea.

Esto no sería una «reinfección». Sería la persistencia de otros integrantes del inóculo original.

Los síntomas pueden continuar después de que el parásito haya desaparecido

La curación parasitológica y la desaparición inmediata de los síntomas no son necesariamente lo mismo.

Una parte importante del síndrome de Halzoun o Marrara parece ser producida por:

• lesión mecánica causada por los cuatro ganchos bucales del parásito;
• inflamación de la mucosa;
• secreciones o antígenos parasitarios;
• hipersensibilidad mediada por eosinófilos;
• edema de la faringe o la nasofaringe;
• ocasionalmente, una infección bacteriana secundaria.

La literatura sobre el síndrome de Marrara lo caracteriza, en buena medida, como una reacción aguda de hipersensibilidad frente a los antígenos de las ninfas. Entre las complicaciones documentadas se encuentran la otitis media, la hipoacusia conductiva, los acúfenos y, en casos excepcionales, la afectación del nervio facial. Estas complicaciones parecen estar relacionadas con una inflamación local intensa o con una infección secundaria. (pubmed.ncbi.nlm.nih.gov)

Por lo tanto, después de la expulsión completa:

• el prurito y la sensación de cuerpo extraño pueden desaparecer rápidamente;
• la inflamación, el edema, la tos o la secreción nasal pueden tardar varios días en resolverse;
• una sinusitis u otitis bacteriana secundaria puede requerir tratamiento específico;
• una reacción grave de hipersensibilidad puede necesitar tratamiento sintomático.

La persistencia de síntomas durante un período breve no implica necesariamente que todavía quede un parásito vivo. Sin embargo, los síntomas focales, persistentes o recurrentes tampoco deben atribuirse automáticamente a una inflamación residual.

¿Puede L. serrata madurar y reproducirse en la nasofaringe humana?

Aquí la respuesta debe ser más cautelosa.

A menudo se describe a los seres humanos como hospedadores definitivos accidentales o aberrantes cuando ingieren ninfas. Algunas revisiones recientes afirman que las ninfas pueden desarrollarse hasta el estadio adulto en las vías respiratorias superiores humanas. Por ejemplo, una revisión de 2024 publicada en Trends in Parasitology incluye a los seres humanos entre los hospedadores en los cuales las ninfas nasofaríngeas podrían madurar. (researchoutput.csu.edu.au)

Sin embargo, otras revisiones destacan que:

• el síndrome humano agudo está normalmente causado por ninfas;
• la infección nasofaríngea humana suele ser autolimitada;
• las ninfas infectantes normalmente no completan su maduración en los seres humanos;
• las infecciones humanas por formas adultas son excepcionalmente raras. (pmc.ncbi.nlm.nih.gov)

La aparente contradicción probablemente refleja la debilidad de la evidencia disponible en seres humanos. Gran parte de la literatura consiste en casos aislados, ejemplares identificados únicamente por su morfología y usos ocasionalmente imprecisos de los términos «adulto», «larva» y «ninfa».

La conclusión más defendible es:

La maduración hasta el estadio adulto podría ocurrir excepcionalmente en seres humanos, pero no se ha demostrado que una infección reproductiva sostenida ni la eliminación de huevos por humanos formen parte de la biología habitual de la linguatuliasis nasofaríngea.

Además, incluso si se produjera la maduración, esto no generaría una multiplicación local rápida. En los hospedadores definitivos normales, la madurez adulta requiere aproximadamente seis meses, y la fecundación normalmente exige la presencia de un macho y una hembra. Los síntomas agudos que comienzan pocas horas después de comer vísceras crudas son, por lo tanto, causados por las propias ninfas ingeridas, no por descendientes producidos dentro del paciente. (ncvetp.org)

¿Podría una persona reinfectarse a sí misma al tragar huevos del parásito?

Este no es un ciclo clínico reconocido.

En teoría, una infección extraordinaria que contuviera adultos machos y hembras maduros y reproductivamente competentes podría producir huevos. Si esos huevos fecundados fueran ingeridos, los seres humanos son biológicamente capaces de actuar como hospedadores intermediarios. Por ello, se podría construir una vía hipotética de autoinfección visceral.

Pero este escenario exigiría varios acontecimientos, todos ellos infrecuentes:

muˊltiples ninfas→supervivencia de machos y hembras→

maduracioˊn adulta→apareamiento→produccioˊn de huevos fecundados→

ingestioˊn de los huevos e invasioˊn de tejidos

No existe evidencia sólida de que esto constituya un mecanismo real y recurrente de autoinfección humana. Debe considerarse, por tanto, biológicamente concebible, pero clínicamente no documentado, y no una parte establecida del ciclo humano.

Tragar una ninfa expulsada o desprendida es una situación diferente. Una ninfa no se transforma en una larva intestinal ni inicia por sí misma una linguatuliasis visceral. Puede ser digerida, eliminada o, posiblemente, intentar adherirse nuevamente a la vía aerodigestiva superior, pero no genera una nueva generación interna. La linguatuliasis visceral suele producirse por la ingestión de huevos, no de ninfas. (pmc.ncbi.nlm.nih.gov)

Conclusión práctica

En un caso nasofaríngeo confirmado y no complicado:

extraccioˊn o expulsioˊn completa de todas las ninfas≈curacioˊn parasitoloˊgica​

Normalmente no existe:

• multiplicación dentro del organismo;
• un ciclo nasofaríngeo autosostenido;
• autoinfección habitual;
• necesidad de tratamiento antiparasitario una vez confirmada la eliminación completa.

Las principales incertidumbres son si se ingirió más de un parásito, si alguno permanece en una localización difícil de visualizar y si persisten una lesión de la mucosa, una reacción de hipersensibilidad o una infección secundaria. Por ello, la extracción mecánica o endoscópica es biológicamente más racional que la administración de un antiparasitario sistémico cuya eficacia no ha sido validada.

El praziquantel se ha utilizado ocasionalmente en algunos casos publicados, pero no es posible separar su efecto de la expulsión espontánea, la extracción mecánica y el curso naturalmente autolimitado de la enfermedad. (pubmed.ncbi.nlm.nih.gov)

En un paciente real, la dificultad respiratoria, el aumento progresivo de la inflamación de la garganta o la cara, la incapacidad para tragar las secreciones, un sangrado importante, la fiebre, los síntomas intensos y unilaterales del oído, o la persistencia de síntomas después de la aparente expulsión justifican una evaluación otorrinolaringológica urgente.

In Depth Review

Claude Artifact

Try out Artifacts created by Claude users

Claude

Human Linguatulosis (Linguatula serrata): A Doctoral Research Essay on Parasite Biology, Clinical Disease, Prognosis, and Treatment

Structured Abstract

QUESTION. What does the pentastomid Linguatula serrata actually do to human beings, and what — if anything — can be done to treat it and predict its course? Embedded in this question are explicit failure conditions. (1) The claim that no evidence-based anthelminthic therapy exists for human linguatulosis fails if any controlled trial, or a consistent case series with a plausible counterfactual, demonstrates drug-attributable nymph clearance distinguishable from spontaneous expulsion. (2) The claim that the two human diseases (nasopharyngeal vs visceral) are caused by one pan-global species fails if molecular data resolve dog-derived and ruminant-derived lineages into diagnostically or reproductively distinct taxa. (3) The claim that human linguatulosis is essentially never fatal fails if a verifiable, autopsy- or clinically-confirmed death attributable specifically to L. serrata (not Armillifer) is documented. (4) The claim that human prevalence figures are uninterpretable fails if a study with a defined denominator, a validated reference standard, and freedom from verification bias reports a human population prevalence.

SPINE. L. serrata is a crustacean-lineage parasite whose adults live in canid nasopharynx and whose nymphs encyst in herbivore viscera. Humans intersect this cycle by two independent routes that produce two diseases with almost nothing clinically in common: eating eggs yields visceral (and rarely ocular) nymphal disease; eating live nymphs yields the acute nasopharyngeal irritative/hypersensitivity syndrome (halzoun/marrara). The entire human evidence base is case reports, small clinical series, autopsy surveys, and abattoir surveys of animals; there are no controlled therapeutic trials, no validated human serology, no case registry, and unresolved species-level taxonomy that undermines attribution. Its evolutionary distance from nematodes and platyhelminths gives a weak pharmacological rationale for the anthelminthics reflexively reached for.

CONCLUSION. Human linguatulosis is real, geographically clustered (Middle East, North/East Africa, South Asia, with sporadic global and imported-dog cases), and almost always self-limited or incidental. Nasopharyngeal disease resolves over hours to roughly two weeks; management is mechanical removal, airway vigilance, and symptomatic care — not chemotherapy. Visceral disease is usually an incidental calcified nodule needing no treatment; surgery is for diagnostic uncertainty or symptomatic burden. There is no proven antiparasitic drug for human tissue nymphs, and killing them pharmacologically is theoretically counter-productive. Prognosis is excellent except for the intraocular form, which threatens vision. The dominant clinical risk to flag once: acute laryngeal/pharyngeal oedema with airway compromise in the nasopharyngeal form.

1. What this parasite is and what it does

Linguatula serrata is a tongue-shaped, blood- and mucus-feeding parasite — not a worm but a highly reduced crustacean — whose adults live in the nasal passages and frontal sinuses of dogs and other canids, and whose larval "nymphs" encyst in the viscera of grazing mammals. People become infected in one of two unrelated ways and thereby get one of two unrelated diseases. If a person swallows the eggs (from a dog, or from egg-contaminated food, water, or soil), the person becomes an accidental intermediate host: larvae hatch, cross the gut wall, and encyst in viscera — occasionally the eye — producing visceral linguatulosis. If a person eats raw or undercooked viscera containing live nymphs, the person becomes an aberrant definitive host: the nymphs attach to the nasopharyngeal mucosa and provoke an acute irritative/hypersensitivity reaction — nasopharyngeal linguatulosis, known as halzoun in Lebanon and Syria and marrara in Sudan. Everything else in this essay elaborates, qualifies, and grades that two-sentence answer.

2. Taxonomy, phylogeny, and biology

2.1 Nomenclature and the synonym trap

Linguatula serrata was described by Frölich in 1789. The older literature is unreadable without its synonyms: the adult was long called Pentastomum taenioides and the nymph Pentastomum denticulatum, so a nineteenth- or early-twentieth-century paper describing these two "species" is describing two life stages of one organism. The genus Linguatula is placed in Pentastomida, order Porocephalida, family Linguatulidae. The genus currently holds a small number of valid species — L. serrata, L. arctica Riley, Haugerud & Nilssen 1987 (reindeer sinuses in the Palearctic, with an unusual ungulate definitive host and a direct life cycle), L. multiannulata, L. recurvata, and L. nuttalli — the last several requiring molecular corroboration, per the systematic monograph of Christoffersen & de Assis (2013) and the nomenclatural work of Poore (2012).

2.2 Phylogenetic position — and why it matters clinically

Pentastomids are not their own phylum of "worms." Molecular and spermatological evidence places them firmly within Arthropoda, as the sister group of the Branchiura (fish lice) within the crustacean superclass Oligostraca — the "Ichthyostraca" hypothesis. The evidentiary arc runs from Abele, Kim & Felgenhauer (1989), who used 18S rRNA to show a Porocephalus/Argulus clade; through Wingstrand's (1972) sperm ultrastructure; to Lavrov, Brown & Boore (2004), whose mitochondrial genome data secured the (pan)crustacean placement; Møller et al. (2008), whose multi-gene phylogeny confirmed the Branchiura–Pentastomida sister relationship; and the broad phylogenomic frameworks of Regier et al. (2010, Nature) and Oakley et al. (2013), which recover Oligostraca (ostracods, mystacocarids, branchiurans, pentastomids). Cambrian fossils assignable to the pentastomid stem-group make the group extremely ancient. A contrary minority view (Almeida & Christoffersen and colleagues) reads some fossils as early-diverging euarthropods outside crown Ichthyostraca; this does not affect the clinical point.

The clinical point is pharmacological. The anthelminthics clinicians reach for — benzimidazoles (β-tubulin binders), macrocyclic lactones (glutamate-gated chloride channel agonists), praziquantel (a platyhelminth Ca²⁺-channel/schistosome drug), levamisole (nematode nicotinic agonist) — were developed against nematodes and platyhelminths, lineages separated from pentastomids by more than half a billion years of evolution. The drug targets are not guaranteed to be conserved, expressed, or accessible in an encapsulated crustacean-lineage nymph. This is the mechanistic root of the therapeutic vacuum discussed in §9; any expectation that "an antiparasitic should work" is a category error dressed as clinical reasoning.

2.3 Morphology and developmental stages

Adults are dorsoventrally flattened, tongue- or leaf-shaped, translucent, and transversely annulated. The female is large — commonly cited at 80–130 mm long and up to ~10 mm wide — while the male reaches only ~20 mm. The anterior end bears a ventral mouth flanked by two pairs of retractile, sclerotised hooks (the "five mouths" impression giving Pentastomida its name is illusory: one mouth, four hooks). The cuticle is chitinous and penetrated by ring-like sclerotised openings of subcuticular glands, a feature diagnostically important in histology. Developmental stages are: embryonated egg (~90 × 70 µm, containing a four-legged primary larva) → primary (mite-like, four-legged) larva → a series of nymphal instars within the intermediate host → infective nymph (flat, slightly annulated, with 72–92 body segments and cuticular spines) → adult in the definitive host. Adult females are extraordinarily fecund: per Mehlhorn's Encyclopedia of Parasitology (Springer, L. serrata entry), "females excrete thousands (up to 5,000,000) eggs per day," and these stages are infectious for plant-feeders including humans. Adult longevity/patency is reported at roughly 15 months to two years; tissue nymphs in an intermediate host degenerate and calcify over approximately two years.

2.4 Cryptic lineages and the attribution problem

"L. serrata" as used in the medical literature is probably a species complex, and this directly undermines the confidence with which any human case is attributed to a single organism. Gjerde (2013) sequenced the complete 18S rRNA gene and a 1,045-bp cox1 fragment from a L. serrata female (expelled from a Romania-imported dog in Norway) and four L. arctica from reindeer: the two species differed at only 2/1,830 18S positions (99.9% identity) but at 102/1,045 cox1 positions (90.2% identity) — establishing cox1 as the discriminating marker and 18S as too conserved. Shamsi, Barton, Zhu & Jenkins (2020, IJP: Parasites and Wildlife) characterised Australian tongue worms and found that Iranian and Bangladeshi "L. serrata" formed a distinct group separated from Australian/European L. serrata by 0.46–2.21% cox1 distance — larger than the 0.12% distance between L. arctica and Australian/European L. serrata — and concluded that Palearctic material "should not be automatically named L. serrata." Hence the deliberate literature usage "Linguatula cf. serrata." Barton et al. (2022, Parasitol Res) added 28S data (6.17–6.46% interspecific difference L. serrata vs L. nuttalli) and recovered an unassigned adult Linguatula from Romanian roe deer. The unresolved question — whether dog-derived and ruminant-derived organisms causing the two human diseases are the same species — is a genuine failure condition for the "one species, two diseases" framing.

3. Life cycle and transmission

Definitive hosts are canids — domestic dogs, foxes, wolves, jackals — with occasional felids; adults inhabit nasal passages and frontal sinuses. Embryonated eggs leave in nasal discharge and, when swallowed, in faeces, contaminating soil, water, and vegetation; eggs can survive in the environment for extended periods under humid conditions.

Intermediate hosts are a broad range of herbivores and others — cattle, sheep, goats, camels, water buffalo, deer, rabbits, rodents, and (in Australia) wallabies and hares — in which nymphs localise chiefly to mesenteric lymph nodes, and also liver, lungs, and spleen. Infective nymphal development takes roughly six months.

Two routes into humans, two diseases:

1. Ingestion of eggs (contaminated food/water/soil, or close contact with an infected dog) → human as accidental intermediate host → visceral (nymphal) linguatulosis, including rare ocular disease when a migrating larva reaches the eye.
2. Ingestion of live nymphs in raw/undercooked viscera → human as aberrant definitive host → nasopharyngeal linguatulosis (halzoun/marrara). The classic vehicles are raw liver and lymph nodes of sheep/goats in Lebanon and Syria, and the Sudanese dish marrara (raw liver, lung, trachea, and rumen of sheep/goats). Rare reports also describe adult L. serrata recovered from the human nasal cavity, i.e. nymphs maturing toward the adult stage in a human aberrant definitive host.

4. History and the halzoun aetiological controversy

Halzoun was clinically described by the Lebanese physician Khoury in 1905 (Archives de Parasitologie) and initially attributed to the liver fluke Fasciola hepatica swallowed in raw liver. The attribution was contested for decades. Witenberg (1944) proposed the leech Limnatis nilotica; Watson & Kerim (1956) described two forms (one Fasciola, one Limnatis). The decisive parasitological work came from the American University of Beirut group: Khalil & Schacher (1965, Am J Trop Med Hyg) showed experimentally that orally administered L. serrata nymphs attach to the pharynx, larynx, trachea, and bronchi of animals and evoke halzoun-/marrara-like symptoms, persisting longest (with some growth) in rabbits; Schacher, Khalil & Salman (1965, J Trop Med Hyg) reported a Lebanese field study; and Schacher, Saab, Germanos & Boustany (1969, Trans R Soc Trop Med Hyg) recovered L. serrata nymphs from two halzoun patients and formally proposed the enduring split between visceral and nasopharyngeal linguatulosis. In Sudan, El-Hassan, Eltoum & El-Asha (1991, Trans R Soc Trop Med Hyg) isolated L. serrata nymphs from a marrara patient and from goat viscera, and Yagi et al. (1996, Acta Tropica) framed marrara explicitly as "a hypersensitivity reaction of the upper respiratory tract and buccopharyngeal mucosa to nymphs of Linguatula serrata."

The honest reading of the controversy: the syndrome called "halzoun" is probably aetiologically heterogeneous. L. serrata is proven to cause a nasopharyngeal syndrome (nymphs recovered from patients). But Khalil, Haddad, Otrock, Jaber & Farra (2013, Acta Tropica) recruited 32 Lebanese patients with typical halzoun (2005–2007), recovered parasites from a patient's expectoration and from the raw sheep liver on patients' plates, and identified them all as the trematode Dicrocoelium dendriticum — not L. serrata and not Fasciola. The methodological caution: "halzoun" is a clinical label, not an etiologic diagnosis; the same presentation can be produced by at least two parasites (a pentastomid and a dicrocoeliid fluke), and possibly by leeches, so any case series lacking recovered-and-identified organisms is aetiologically ambiguous. The experimental/volunteer evidence (Khalil & Schacher) is animal-model and small; it establishes plausibility and mechanism, not population attribution.

5. Epidemiology

5.1 Negative and cautionary findings first

No study reports a human population prevalence of linguatulosis with a defined denominator and a validated reference standard. Human serosurveys use unvalidated in-house ELISAs against nymphal antigens with no gold standard and known cross-reactivity risk. The human clinical literature is a convenience sample of case reports subject to severe publication and referral bias. Species attribution is uncertain (§2.4). Animal abattoir surveys, which are numerous, measure the animal reservoir, not human risk, and are themselves heterogeneous in examination method (visual inspection vs acid-pepsin digestion), organ sampled, season, host age, and breed.

5.2 Distribution

Endemic foci and reported cases cluster in the Middle East (Lebanon, Syria, Iraq, Iran), North and East Africa (Sudan, Egypt, Morocco, Tunisia), Turkey, and South Asia (India, Pakistan, Bangladesh), with sporadic cases in Latin America (Ecuador, Brazil, Colombia, Costa Rica, Peru), Europe (Germany, Italy, Austria, Romania, and increasingly imported-dog cases in the UK/Scandinavia), North America, and Australia.

5.3 Animal reservoir — with denominators

Definitive-host (dog) surveys report high adult prevalence in endemic areas: Oryan, Sadjjadi, Mehrabani & Rezaei (2008) found L. serrata in 65/85 (76.5%) stray dogs in Shiraz, Iran; Khalil & Schacher (1965) found 43.3% of 30 stray Beirut dogs infected; Yagi et al. (1996) reported 56% of male and 47% of female dogs infected in the endemic Sudanese area. Intermediate-host (ruminant/camel) nymphal surveys are dominated by Iranian abattoir studies. Representative figures: Rezaei, Tavassoli & Javdani (2012) found that 21.12% of 232 slaughtered camels (49 animals) in Isfahan Province harboured L. serrata nymphs; a North-West Iran study found 105/200 (52.5%) of sheep infected, with infection concentrated in haemorrhagic (78.0%) and black-coloured (86.3%) nodes versus normal nodes (9.3%); Ahvaz abattoir cattle/buffalo showed 37/223 (16.6%) infected. The Iranian meta-analysis (Tabaripour, Shokri, Hosseini Teshnizi, Fakhar & Keighobadi 2019, Parasite Epidemiol Control) pooled 50 studies and estimated random-effects prevalences of 25% in goats, 15% in sheep, and 12% in cattle, with extreme heterogeneity (I² > 97%) and regional highs of ~68% (Tabriz/East Azerbaijan) and ~60% (Urmia/West Azerbaijan). Hajipour & Tavassoli (2019, Vet Parasitol Reg Stud Reports) reached similar conclusions across Iran and other countries. Comparable ranges are reported elsewhere: Attia et al. (2017) found "the total prevalence of linguatulosis was 22.8% in herbivorous animals" in Egypt, "with highest infection in goats (30%) and lowest in donkeys (8%)"; and Islam et al. (2018) found "50.7% of cattle and 31.0% of goats" infected in Bangladesh (mesenteric lymph nodes affected in 50.9%), concluding the human population is "at high risk." The take-home: the animal reservoir is large and patchy, consistent with endemic human exposure but not a measure of human disease.

5.4 Human epidemiology — the actual counts

The best global synthesis is Tabaripour, Keighobadi, Sharifpour, Azadeh, Shokri, Banimostafavi, Fakhar & Abedi (2021, Parasitol Res), which included 62 human cases from 30 papers (1940–2019): mean age 25.8 years (range 8–79); 41 female (66.1%), 21 male (33.9%); the largest national contribution was Sudan (n = 25); the nasopharynx was the most frequently involved site, and the paper reports that the nasopharyngeal (halzoun/marrara) form was the commonest, at 74.2% of cases. (The full visceral-versus-ocular numeric breakdown and complete country table are not in the accessible abstract; this is a data-availability limitation.) A companion Iranian systematic review (Keighobadi/Tabaripour et al., J Parasit Dis 2021) found Iranian cases in eight provinces with a female preponderance (~60:40) and a modal age of 30–40 years — a demographic pattern that most plausibly reflects food-preparation exposure (tasting raw liver while cooking) rather than any biological sex difference in susceptibility, though this is inference, not demonstrated.

The historical autopsy signal is real and worth stating precisely, because it is the one place the visceral form appears with a denominator: Tappe et al. (2006, Emerg Infect Dis, "Linguatuliasis in Germany") record verbatim that "in 1904 and 1905, among 400 autopsies in Berlin, 47 (11.8%) remains were infected with L. serrata" — evidence that visceral linguatulosis was once common and usually silent in Central Europe. This must not be conflated with the much higher autopsy prevalences that pertain chiefly to Armillifer, a different genus: Prathap, Lau & Bolton (1969, Am J Trop Med Hyg) found a pentastomiasis prevalence of 45.5% in adult Malaysian aborigines at autopsy, and Smith et al. (1975) found Armillifer in 33% of Nigerian patients autopsied after malignancy deaths.

Marrara at the community level: Yagi et al. (1996) reported that "a survey that included 240 adult individuals in a village of endemic L. serrata infection in the Sudan showed that 20% experienced symptoms of allergic nasopharyngitis (Marrara syndrome) following the consumption of raw viscera of goats or sheep at least once in their life"; their prospective series of 24 marrara patients documented throat/nose itching, unilateral conductive deafness, tinnitus, and facial palsy, with secondary bacterial suppurative otitis media in some.

Risk factors are consistent across reports: consumption of raw/undercooked liver, lymph nodes, and viscera; dog ownership/close canine contact (for the visceral/egg route); and occupational exposure (butchers, abattoir workers, veterinarians). Whether human incidence is rising or falling cannot be determined; apparent increases (e.g., imported-dog canine cases in Western Europe) reflect animal-movement and diagnostic awareness, not measured human trends.

6. Pathogenesis and immunology

6.1 Visceral form

Ingested eggs release primary larvae that penetrate the gut and migrate to viscera, where they encyst and molt. Tappe & Büttner (2009, PLoS NTD) describe three histological lesion types that map onto the natural history: (1) a viable nymph in a thin fibrous capsule with little cellular reaction (the living nymph sheds little antigen); (2) the necrotic pentastomid granuloma — the commonest long-standing lesion — where a dying nymph releases abundant antigen, drawing macrophages, giant cells, lymphocytes, plasma cells, and often many eosinophils, with a concentric fibrous, sometimes calcified, "target"-like capsule; and (3) the granulomatous scar/cuticle granuloma, an acellular hyalinised nodule with only cuticular remnants. The clinically important corollary: the inflammatory burden is greatest when the nymph dies. Lesions are 2–8 mm ("Linguatula nodules"), favouring subperitoneal tissue around liver, mesentery, spleen, and intestinal wall.

6.2 Nasopharyngeal form

Halzoun/marrara is best understood as an acute irritative and hypersensitivity reaction to nymphs mechanically attaching (via hooks) to the naso-/oropharyngeal and laryngeal mucosa within minutes to a few hours of eating infected raw viscera. The hypersensitivity framing (Yagi et al. 1996) is supported by the symptom complex (oedema, urticaria, lacrimation, sneezing), by the dermatological observation of major-basic-protein (eosinophil) involvement (Buslau, Kühne & Marsch 1990, Dermatologica), and by Khalil & Schacher's (1965) finding that previously egg-sensitised animals reacted more strongly to introduced nymphs. It is essentially a live-parasite exposure that the host clears mechanically (by expelling the nymphs through coughing/sneezing/vomiting) over hours to about two weeks. Direct human immunological data (IgE titres, cytokine profiles) are sparse; most mechanistic support is animal-model (Khalil & Schacher 1965; the broader pentastomid biology of Self 1972 and Riley 1986, Adv Parasitol) and a rat behavioural model (2018) showing sneezing and grooming after nymph ingestion.

7. Clinical manifestations

Adverse/atypical presentations first: visceral linguatulosis has masqueraded as hepatic or pulmonary malignancy, prompting thoracotomy or laparotomy (Tappe & Büttner 2009; Machado et al. 2006, liver "tumour"; Baird, Kassebaum & Ludwig 1988, hepatic granuloma in a North American man; Gardiner, Dyke & Shirley 1984, Michigan); a nodular pulmonary lesion has been reported in an HIV-positive man (Pampiglione et al. 2001); and the nasopharyngeal form has caused facial palsy, conductive deafness, and suppurative otitis media (Yagi et al. 1996). These mimics are the main source of iatrogenic harm.

Table 1. Comparison of human clinical forms of L. serrata infection

7.1 Nasopharyngeal linguatulosis (halzoun/marrara)

Symptoms begin within minutes to a few hours of the raw-viscera meal: intense throat and nasal itching and pain, foreign-body sensation, dysphagia, dysphonia/hoarseness, paroxysmal cough, sneezing, nasal discharge and obstruction, epistaxis, lacrimation, conjunctival injection, otalgia, headache, and sometimes urticaria and low-grade fever. Cases resolve typically over a few days up to about two weeks, often with expulsion of nymphs by coughing/sneezing/vomiting. The complication to respect once, directly: acute pharyngeal/laryngeal oedema can threaten the airway. Additional complications include secondary bacterial otitis media and, in the Sudanese series, facial palsy and conductive deafness.

7.2 Visceral linguatulosis

Most cases are silent — an incidental finding at autopsy, surgery, or imaging (the Berlin autopsy series is the clearest denominator: 11.8%). Symptomatic disease reflects nymph location and death: abdominal pain, hepatomegaly, mesenteric lymphadenopathy mimicking lymphoma/TB, pulmonary nodules mimicking metastatic malignancy, and rarely peritonitis or obstruction. The dominant morbidity is diagnostic: mistaken malignancy leading to major surgery.

7.3 Ocular linguatulosis

A small but clinically serious set of intraocular/subconjunctival cases, essentially all attributed to a single migrating nymph. Documented reports include the anterior-chamber cases from the southern United States (Deweese, Murrah & Caruthers 1962, Arch Ophthalmol; Rendtorff, Deweese & Murrah 1962, Am J Trop Med Hyg), a Portuguese case (Sousaefaro & Pinhão 1964), an Israeli case with iritis, lens subluxation and secondary glaucoma in a boy (Lang, Garzozi, Epstein, Barkay, Gold & Lengy 1987, Br J Ophthalmol), an Ecuadorian case with a detailed morphometric larval study (Lazo et al. 1999, Am J Trop Med Hyg), an Austrian case in a 14-year-old girl with molecular confirmation and vitrectomy (Koehsler et al. 2011, Emerg Infect Dis), and Indian anterior-chamber cases (Pal et al. 2011, Ocul Immunol Inflamm; Bhende et al. 2014, Indian J Ophthalmol). Intraocular nymphs cause uveitis, secondary glaucoma, and mechanical/retinal damage; ocular-adnexal (extraocular) nymphs have a better prognosis than intraocular ones.

7.4 Adults in the human nose; special hosts

Rare reports describe L. serrata recovered from the human nasal cavity/throat as maturing/adult stages (e.g., Maleky 2001, Tehran). Cases occur in children (the ocular cases especially) and adults; the single HIV-positive pulmonary case (Pampiglione et al. 2001) is the only clearly immunocompromised host in the prominent literature. No pregnancy-specific data exist.

8. Diagnosis

Negative/limiting facts first: there is no validated, commercially available serological test for human linguatulosis; no established PCR for routine diagnosis from formalin-fixed human tissue (formalin fixation degrades DNA); and degenerated or calcified nymphs may retain only hooks and cuticular remnants, defeating species-level identification.

• Morphology of expelled/excised nymphs: the definitive nasopharyngeal and ocular diagnosis. Key features: flattened, annulated body (72–92 segments), two pairs of oral hooks, cuticular spines, and (in L. serrata specifically) prominent cuticular spines distinguishing it from Armillifer (cylindrical with ~20 prominent rings), Porocephalus (annulated, 38–40 segments), and other pentastomes (Leiperia, Sebekia in reptiles).
• Histopathology (Tappe & Büttner 2009; Ma, Qiu & Rong 2002, Trop Med Int Health): the diagnostic quintet is the chitinous cuticle with sclerotised openings, oral hooks retractable by striated muscle, acidophilic gland cells, striated muscle in the body wall, and the shed exuvia; Movat pentachrome or Masson trichrome best reveal cuticular openings. The "target"-like concentric granuloma with a coiled C-shaped nymph is characteristic.
• Imaging: calcified nodules on CT/US/radiograph; L. serrata less often shows the pathognomonic comma/horseshoe calcifications typical of Armillifer. Imaging's main job is to distinguish these from malignancy, TB, and hydatid disease.
• Molecular: research use of 18S rRNA (conserved; genus/species-poor discrimination), cox1 (discriminating; the marker of choice), and 28S rRNA on fresh/expelled specimens; GenBank reference coverage for Linguatula is still thin.

Table 2. Differential diagnosis

9. Treatment options

9.1 The central negative finding

There is no antiparasitic chemotherapy of proven efficacy for human linguatulosis, and none for tissue-stage pentastome nymphs generally (Tappe & Büttner 2009 state flatly: "There is no antiparasitic chemotherapy available for pentastomiasis"). No controlled trial exists in humans. Every therapeutic claim rests on uncontrolled case reports in which spontaneous nymph expulsion (nasopharyngeal) or spontaneous nymph degeneration over ~2 years (visceral) is an untestable confounder: because both forms resolve without treatment, drug attribution is unfounded absent a counterfactual.

9.2 By clinical form

• Nasopharyngeal (halzoun/marrara): management is mechanical and symptomatic — direct/endoscopic removal of visible nymphs; airway assessment and protection where oedema is significant; corticosteroids and antihistamines for the hypersensitivity component; analgesia; saline (or, per one Lebanese group, alcohol) gargles. Khalil & Schacher (1965) suggested local anaesthetic and antihistaminic drugs. Natural history is self-limited over hours to ~2 weeks, which is precisely why no drug can be credited.
• Visceral: for asymptomatic calcified lesions, no treatment (Tappe & Büttner: parasites degenerate after ~2 years). Surgical excision is indicated for diagnostic uncertainty (to exclude malignancy/TB) or for symptomatic heavy infection.
• Ocular: surgical removal is the treatment — anterior-chamber paracentesis/washout for anterior-segment nymphs, pars plana vitrectomy for posterior migration (as in Koehsler et al. 2011, where the mobile parasite escaped to the posterior segment and was removed after lensectomy and vitrectomy, with recovery of vision to 1.0 Snellen after later IOL implantation) — with adjunctive corticosteroids for inflammation.

9.3 Drugs used or proposed in humans

No human case demonstrates drug-attributable nymph clearance distinguishable from natural expulsion/degeneration. Ivermectin, albendazole, mebendazole, praziquantel, and levamisole appear in the pentastomiasis literature largely by analogy or anecdote, without controlled evidence. This is the state of the evidence, not an omission in the search.

9.4 Animal and in vitro efficacy data

The most informative efficacy data are veterinary and concern the definitive-host (dog) adult infection, not human tissue nymphs:

• Multiple imported-dog case reports (Germany: Globokar et al. 2005; UK: Villedieu et al. 2017 and Macrelli et al. 2022; Romania/Italy: Marchetti et al. 2023; Greece: a 2016 case) describe clinical resolution after macrocyclic lactones — oral milbemycin oxime, moxidectin/imidacloprid spot-on, or milbemycin oxime/praziquantel — and/or endoscopic/mechanical removal and nasal lavage. Crucially, several of these same reports document spontaneous expulsion of adult worms by sneezing before or without effective drug therapy, and at least one notes that repeated praziquantel/pyrantel/febantel (Drontal Plus) did not eliminate infection — again confounding attribution.
• For the congeneric reindeer sinus worm, Haugerud, Nilssen & Rognmo reviewed ivermectin against L. arctica with limited efficacy — a caution that macrocyclic lactones are not reliably parasiticidal even against adult Linguatula.
• No robust in vitro nymphicidal data for L. serrata exist.

9.5 The danger of killing tissue nymphs, and the pharmacological rationale

The Armillifer literature warns that killing tissue-stage nymphs can worsen inflammation: dying nymphs release large antigen loads (the mechanism behind the necrotic granuloma; Tappe & Büttner 2009), and severe/fatal Armillifer disease is associated with heavy, dying-nymph burdens (Drabick 1987, Rev Infect Dis; Vanhecke et al. 2016, Med Mal Infect; the lethal A. armillatus case of Lavarde & Fornes 1999). By extension, chemically killing encapsulated L. serrata nymphs is theoretically counter-productive as well as unproven. The pharmacological rationale against a crustacean-lineage parasite is weak on first principles (§2.2): whether glutamate-gated chloride channels, β-tubulin isotypes, or nicotinic targets are conserved, drug-accessible, and lethal in an encysted pentastome nymph is unknown — this is explicitly speculative, and should be marked as such wherever a drug is "tried."

Table 3. Reported/plausible treatments and outcomes, with attribution caveats

Table 4. Evidence-graded management algorithm

10. Prognosis

10.1 Nasopharyngeal form

Excellent. Typical duration is hours to ~2 weeks with spontaneous resolution as nymphs are expelled or die and are cleared. Re-exposure causes recurrence (a behaviour-driven, not immunity-driven, pattern). Complications — laryngeal oedema, otitis media, facial palsy, conductive deafness — are uncommon and generally reversible. Regarding mortality: despite frequent assertions that halzoun "can be fatal" through airway obstruction, I could not verify a single documented, individually reported death attributable specifically to L. serrata nasopharyngeal disease; the blanket "fatal" claims in some reviews are unsupported by a citable case. Documented pentastomiasis fatalities in the literature involve Armillifer (heavy visceral loads), not Linguatula. The airway risk is therefore real in mechanism and worth flagging once, but the empirical case-fatality record for L. serrata is essentially null.

10.2 Visceral form

Also excellent, precisely because it is usually silent. Nymphs degenerate and calcify over roughly two years, leaving an inert scar. The morbidity that does occur is largely iatrogenic — thoracotomy/laparotomy performed for suspected malignancy or TB. No verifiable death is attributable to human visceral L. serrata (again in contrast to Armillifer).

10.3 Ocular form

The one form with a guarded prognosis. Intraocular nymphs cause uveitis, secondary glaucoma, cataract/lens damage, and retinal injury; outcomes depend on prompt surgical removal. Timely intervention can preserve or restore vision (Koehsler et al. 2011: final acuity 1.0 Snellen), but delay risks permanent visual loss, and intraocular location carries worse prognosis than ocular-adnexal location.

10.4 Prognostic factors and their evidence quality

Reported prognostic factors — parasite burden, location (intraocular worst), promptness of removal, and whether the nymph is alive or dying (dying nymphs drive inflammation) — derive entirely from case-level observation and pathophysiological inference, not from cohort studies. Evidence quality is low; these are reasonable heuristics, not validated predictors.

11. Prevention, control, and One Health

Interventions are logical and near-universally recommended, but almost none has measured effectiveness against human linguatulosis. The mainstays: thorough cooking (or freezing) of viscera before consumption to kill nymphs; meat inspection and condemnation of infected offal at slaughter; deworming/treatment of dogs and preventing canine access to raw offal (to interrupt egg output); hand hygiene after dog contact; and culturally informed education in endemic communities (Lebanon, Syria, Sudan, Iran) targeting the specific dish and habit (raw liver, kubbeh nayeh, marrara). For imported dogs, veterinary guidance (e.g., ESCCAP-type recommendations) and clinician awareness of L. serrata as a differential in the coughing/sneezing imported dog reduce establishment of new endemic foci in non-endemic regions. Documented cooking temperature/time thresholds specific to L. serrata nymph inactivation are not well established in the literature — a genuine gap.

12. Critical appraisal and research agenda

Evidence hierarchy of the human literature. It is almost entirely: (i) single case reports and small clinical series (halzoun/marrara, ocular, visceral); (ii) autopsy series (historical, e.g., Berlin 1904–05); and (iii) abattoir surveys of animals. There are no randomised or controlled human trials, no validated serology, no established human PCR pipeline for archival tissue, and no case registry. Attribution is undermined by taxonomic uncertainty (§2.4). The literature is saturated with verification/referral bias (only worked-up or dramatic cases are reported) and publication bias (positive/curious cases published; null follow-ups not).

What a rigorous program would look like. (1) A prospective case registry with standardised case definitions distinguishing the three forms and requiring recovered-and-identified organisms for attribution. (2) Validated serology built and tested against a proper reference standard (recovered-parasite-confirmed cases and true negatives), reporting sensitivity/specificity with confidence intervals and cross-reactivity testing against Fasciola, Dicrocoelium, and Armillifer. (3) Molecular typing (cox1/28S) of human isolates to settle whether human disease is caused by one species or several. (4) During marrara/halzoun clusters, pragmatic, well-designed observational comparisons (or, ethically, cluster-level pragmatic trials) of symptomatic treatments, with pre-specified endpoints (time to symptom resolution, airway events). (5) Controlled animal-model and in vitro drug-efficacy studies against L. serrata nymphs and adults, explicitly powered and blinded. Each of these directly addresses one of the essay's failure conditions; if, for instance, a controlled trial showed drug-attributable nymph clearance, the "no effective chemotherapy" conclusion should be revised.

13. Comparative context: Linguatula vs Armillifer and Porocephalus

Much "human pentastomiasis" treatment and prognosis data are pooled across genera, and the pooling is misleading. Armillifer spp. (definitive host: snakes; acquired by eating snake meat or via snake-secretion-contaminated water/food; endemic in West/Central Africa and parts of Asia) cause visceral pentastomiasis that is usually asymptomatic and incidental but that, in heavy infections, has caused the documented fatalities and severe disease (Drabick 1987; Vanhecke et al. 2016; Lavarde & Fornes 1999; the "worm-eaten heart" cardiac cases). Porocephalus is rarer in humans. What transfers from this literature to L. serrata: the histopathological lesion types and the principle that dying nymphs drive inflammation; the absence of proven chemotherapy; and the general rule of "excise if symptomatic, observe if not." What does not transfer: the mortality/severity profile (heavy Armillifer loads can kill; L. serrata essentially does not), the pathognomonic comma-shaped calcifications (more typical of Armillifer), the epidemiology (snake-meat vs raw-ruminant-viscera/dog contact), and — critically — the acute nasopharyngeal halzoun/marrara syndrome, which is essentially unique to L. serrata among the human-infecting pentastomes because only Linguatula uses a mammalian carnivore definitive host whose niche a human diner can transiently occupy.

Recommendations (staged, with change thresholds)

For the front-line clinician (endemic or with a travel/food history).

1. In a patient with acute throat/nasal irritation, dysphagia, cough, and sneezing beginning minutes to hours after eating raw or undercooked liver/viscera, make a clinical diagnosis of nasopharyngeal linguatulosis (or its differential — dicrocoeliasis, fascioliasis, leech). First act: assess the airway. If there is significant pharyngeal/laryngeal oedema, treat as an airway emergency (positioning, corticosteroid, prepare for advanced airway) — this single threshold overrides all else.
2. If the airway is safe, manage symptomatically (antihistamine, analgesia, saline gargle) and remove any visible nymph endoscopically; do not prescribe antiparasitic drugs — they have no proven benefit and a theoretical harm. Expect resolution within two weeks. Change threshold: symptoms persisting beyond ~2–3 weeks should prompt reconsideration of the diagnosis, not escalation of antiparasitics.
3. For an incidental calcified visceral nodule in an asymptomatic patient, do not operate to treat the parasite; document and reassure. Change threshold: operate only if malignancy or TB cannot be excluded, or if symptomatic heavy infection is present — and send tissue for histology (Movat/Masson stains) and, if fresh, cox1 sequencing.
4. For any intraocular motile parasite, refer to ophthalmology urgently for surgical removal; time-to-removal is the main modifiable prognostic factor.

For the diagnostician. Attribute a case to L. serrata only on recovered-and-identified organism (morphology plus, ideally, cox1). Treat "halzoun" as a syndrome, not an etiology.

For public health and veterinary services. Prioritise the two interventions with the clearest mechanistic leverage: (a) messaging against consumption of raw viscera targeting the specific local dish, and (b) canine deworming plus denial of raw-offal access to dogs. Screen and treat imported dogs from endemic regions.

For researchers. Build the case registry and validated cox1-anchored serology first; these unlock everything else and directly test the essay's failure conditions.

Caveats

• Species uncertainty. Much of what is written as "L. serrata" may be a complex; human-case attribution is correspondingly soft. The "one species, two diseases" model is a working hypothesis, not a settled fact.
• Case-report epistemics. Nearly all human clinical knowledge is hypothesis-generating case material with publication, referral, and verification bias; prevalence and treatment inferences from it are weak. The only denominator-bearing human datum for the visceral form is a >120-year-old autopsy series (Berlin, 11.8% of 400).
• Therapeutic nihilism is evidence-based here. "No effective drug" reflects both absent trials and a weak mechanistic prior (crustacean-lineage target). It is not a claim that a drug could never work — only that none is presently justified.
• Mortality. The airway risk in the nasopharyngeal form is mechanistically real, but I found no verifiable, individually documented human death attributable specifically to L. serrata; reports of fatal pentastomiasis concern Armillifer. This should be revisited if a confirmed L. serrata fatality is published.
• Some cited items are secondary or older primary sources (e.g., Khoury 1905, Watson & Kerim 1956, Self 1972, Fain 1975) verified through their citation in modern reviews rather than by direct full-text inspection; where a full-text abstract could not be independently confirmed, the citation should be treated as bibliographic, not as vetted primary data. The exact visceral-vs-ocular case split within Tabaripour et al. 2021 could not be extracted from the accessible abstract.
• Research-integrity note. During source retrieval, one third-party search-result snippet contained injected text attempting to induce fabricated tool outputs. It was ignored; no content from it was used, and it had no bearing on any figure reported here. Disclosed for transparency.

References (Vancouver)

1. Frölich JA. Beschreibungen einiger neuen Eingeweidewürmer. Der Naturforscher (Halle). 1789;24:101–162.
2. Christoffersen ML, de Assis JE. A systematic monograph of the recent Pentastomida, with a compilation of their hosts. Zool Meded. 2013;87:1–206.
3. Poore GCB. The nomenclature of the recent Pentastomida (Crustacea), with a list of species and available names. Syst Parasitol. 2012;82:211–240. doi:10.1007/s11230-012-9363-x.
4. Abele LG, Kim W, Felgenhauer BE. Molecular evidence for inclusion of the phylum Pentastomida in the Crustacea. Mol Biol Evol. 1989;6:685–691.
5. Wingstrand KG. Comparative spermatology of a pentastomid, Raillietiella hemidactyli, and a branchiuran crustacean, Argulus foliaceus. K Dan Vidensk Selsk Biol Skr. 1972;19:1–72.
6. Lavrov DV, Brown WM, Boore JL. Phylogenetic position of the Pentastomida and (pan)crustacean relationships. Proc Biol Sci. 2004;271:537–544. doi:10.1098/rspb.2003.2631.
7. Møller OS, Olesen J, Avenant-Oldewage A, Thomsen PF, Glenner H. First maxillae suction discs in Branchiura (Crustacea): development and evolution in light of the first molecular phylogeny of Branchiura, Pentastomida, and other "Maxillopoda." Arthropod Struct Dev. 2008;37:333–346. doi:10.1016/j.asd.2007.12.002.
8. Regier JC, Shultz JW, Zwick A, Hussey A, Ball B, Wetzer R, Martin JW, Cunningham CW. Arthropod relationships revealed by phylogenomic analysis of nuclear protein-coding sequences. Nature. 2010;463:1079–1083. doi:10.1038/nature08742.
9. Oakley TH, Wolfe JM, Lindgren AR, Zaharoff AK. Phylotranscriptomics to bring the understudied into the fold: monophyletic Ostracoda, fossil placement, and pancrustacean phylogeny. Mol Biol Evol. 2013;30:215–233. doi:10.1093/molbev/mss216.
10. Gjerde B. Phylogenetic position of Linguatula arctica and Linguatula serrata (Pentastomida) inferred from the nuclear 18S rRNA gene and the mitochondrial cytochrome c oxidase subunit I gene. Parasitol Res. 2013;112:3517–3525. doi:10.1007/s00436-013-3534-9.
11. Shamsi S, Barton DP, Zhu X, Jenkins DJ. Characterisation of the tongue worm, Linguatula serrata (Pentastomida: Linguatulidae), in Australia. Int J Parasitol Parasites Wildl. 2020;11:149–157. doi:10.1016/j.ijppaw.2020.01.010.
12. Shamsi S, McSpadden K, Baker S, Jenkins DJ. Occurrence of tongue worm, Linguatula cf. serrata (Pentastomida: Linguatulidae) in wild canids and livestock in south-eastern Australia. Int J Parasitol Parasites Wildl. 2017;6:271–277.
13. Barton DP, Gherman CM, Zhu X, Shamsi S. Characterization of tongue worms, Linguatula spp. (Pentastomida) in Romania, with the first record of an unknown adult Linguatula from roe deer. Parasitol Res. 2022;121:2379–2388. doi:10.1007/s00436-022-07566-9.
14. Khoury A. Le Halzoun. Arch Parasitol. 1905;9:78–94.
15. Khalil GM, Schacher JF. Linguatula serrata in relation to halzoun and the marrara syndrome. Am J Trop Med Hyg. 1965;14:736–746. doi:10.4269/ajtmh.1965.14.736.
16. Schacher JF, Khalil GM, Salman S. A field study of halzoun (parasitic pharyngitis) in Lebanon. J Trop Med Hyg. 1965;68:226–230.
17. Schacher JF, Saab S, Germanos R, Boustany N. The aetiology of halzoun in Lebanon: recovery of Linguatula serrata nymphs from two patients. Trans R Soc Trop Med Hyg. 1969;63:854–858. doi:10.1016/0035-9203(69)90131-X.
18. El-Hassan AM, Eltoum IA, El-Asha BMA. The marrara syndrome: isolation of Linguatula serrata nymphs from a patient and the viscera of goats. Trans R Soc Trop Med Hyg. 1991;85:309.
19. Yagi H, El Bahari S, Mohamed HA, Ahmed el-R S, Mustafa B, Mahmoud M, Saad MBA, Sulaiman SM, El Hassan AM. The marrara syndrome: a hypersensitivity reaction of the upper respiratory tract and buccopharyngeal mucosa to nymphs of Linguatula serrata. Acta Trop. 1996;62:127–134. doi:10.1016/S0001-706X(96)00017-4.
20. Khalil G, Haddad C, Otrock ZK, Jaber F, Farra A. Halzoun, an allergic pharyngitis syndrome in Lebanon: the trematode Dicrocoelium dendriticum as an additional cause. Acta Trop. 2013;125:115–118. doi:10.1016/j.actatropica.2012.09.013.
21. Fain A. Les pentastomes de l'homme (Pentastomida parasitic in man). Ann Soc Belg Med Trop. 1975 (cited via secondary review).
22. Self JT. Pentastomida. In: Schmidt GD, Roberts LS, eds. Foundations of Parasitology. 1972 (cited via secondary review).
23. Riley J. The biology of pentastomids. Adv Parasitol. 1986;25:45–128. doi:10.1016/S0065-308X(08)60342-5.
24. Drabick JJ. Pentastomiasis. Rev Infect Dis. 1987;9:1087–1094. doi:10.1093/clinids/9.6.1087.
25. Tappe D, Büttner DW. Diagnosis of human visceral pentastomiasis. PLoS Negl Trop Dis. 2009;3:e320. doi:10.1371/journal.pntd.0000320.
26. Tappe D, Winzer R, Büttner DW, Ströbel P, Stich A, Klinker H, Frosch M. Linguatuliasis in Germany. Emerg Infect Dis. 2006;12:1034–1036. doi:10.3201/eid1206.051413.
27. Vanhecke C, Le-Gall P, Le Breton M, Malvy D. Human pentastomiasis in sub-Saharan Africa. Med Mal Infect. 2016;46:269–275. doi:10.1016/j.medmal.2016.02.006.
28. Koehsler M, Walochnik J, Georgopoulos M, Pruente C, Boeckeler W, Auer H, Barisani-Asenbauer T. Linguatula serrata tongue worm in human eye, Austria. Emerg Infect Dis. 2011;17:870–872. doi:10.3201/eid1705.100790.
29. Lazo RF, Hidalgo E, Lazo JE, Bermeo A, Llaguno M, Murillo J, Teixeira V. Ocular linguatuliasis in Ecuador: case report and morphometric study of the larva of Linguatula serrata. Am J Trop Med Hyg. 1999;60:405–409.
30. Deweese MW, Murrah WF, Caruthers SB. Case report of a tongue worm (Linguatula serrata) in the anterior chamber. Arch Ophthalmol. 1962;68:587–589.
31. Rendtorff RC, Deweese MW, Murrah W. The occurrence of Linguatula serrata, a pentastomid, within the human eye. Am J Trop Med Hyg. 1962;11:762–764.
32. Lang Y, Garzozi H, Epstein Z, Barkay S, Gold D, Lengy J. Intraocular pentastomiasis causing unilateral glaucoma. Br J Ophthalmol. 1987;71:391–395. doi:10.1136/bjo.71.5.391.
33. Pal SS, Bhargava M, Kumar A, Mahajan N, Das S, et al. An unusual intraocular tongue worm in anterior chamber: a case report. Ocul Immunol Inflamm. 2011;19:442–443. doi:10.3109/09273948.2011.621579.
34. Bhende M, Biswas J, Raman M, Bhende PS. Linguatula serrata in the anterior chamber of the eye. Indian J Ophthalmol. 2014;62:1159–1161. doi:10.4103/0301-4738.149145.
35. Baird JK, Kassebaum LJ, Ludwig GK. Hepatic granuloma in a man from North America caused by a nymph of Linguatula serrata. Pathology. 1988;20:198–199.
36. Gardiner CH, Dyke JW, Shirley SF. Hepatic granuloma due to a nymph of Linguatula serrata in a woman from Michigan: a case report and review of the literature. Am J Trop Med Hyg. 1984;33:187–189.
37. Machado MA, Makdissi FF, Canedo LF, et al. Unusual case of pentastomiasis mimicking liver tumor. J Gastroenterol Hepatol. 2006;21:1218–1220.
38. Pampiglione S, Gentile A, Maggi P, Scattone A, Sollitto F. A nodular pulmonary lesion due to Linguatula serrata in an HIV-positive man. Parassitologia. 2001;43:105–108.
39. Symmers WSC, Valteris K. Two cases of human infestation by larvae of Linguatula serrata. J Clin Pathol. 1950;3:212–219.
40. Ma KC, Qiu MH, Rong YL. Pathological differentiation of suspected cases of pentastomiasis in China. Trop Med Int Health. 2002;7:166–177.
41. Buslau M, Kühne U, Marsch WC. Dermatological signs of nasopharyngeal linguatulosis (halzoun, marrara syndrome) — the possible role of major basic protein. Dermatologica. 1990;181:327–329.
42. Siavashi MR, Assmar M, Vatankhah A. Nasopharyngeal pentastomiasis (halzoun): report of 3 cases. Iran J Med Sci. 2002;27:191–192.
43. Maleky F. A case report of Linguatula serrata in human throat from Tehran, central Iran. Indian J Med Sci. 2001;55:439–441.
44. Yazdani R, Sharifi I, Bamorovat M, Mohammadi MA. Human linguatulosis caused by Linguatula serrata in the city of Kerman, south-eastern Iran — case report. Iran J Parasitol. 2014;9:282–285.
45. Yilmaz H, Cengiz ZT, Çiçek M, Dülger AC. A nasopharyngeal human infestation caused by Linguatula serrata nymphs in Van province: a case report. Turkiye Parazitol Derg. 2011;35:47–49.
46. Tabaripour R, Keighobadi M, Sharifpour A, Azadeh H, Shokri A, Banimostafavi ES, Fakhar M, Abedi S. Global status of neglected human Linguatula infection: a systematic review of published case reports. Parasitol Res. 2021;120:3045–3050. doi:10.1007/s00436-021-07272-y.
47. Tabaripour R, Shokri A, Hosseini Teshnizi S, Fakhar M, Keighobadi M. Status of Linguatula serrata infection in livestock: a systematic review with meta-analysis in Iran. Parasite Epidemiol Control. 2019;7:e00111. doi:10.1016/j.parepi.2019.e00111.
48. Hajipour N, Tavassoli M. Prevalence and associated risk factors of Linguatula serrata infection in definitive and intermediate hosts in Iran and other countries: a systematic review. Vet Parasitol Reg Stud Reports. 2019;16:100288. doi:10.1016/j.vprsr.2019.100288.
49. Oryan A, Sadjjadi SM, Mehrabani D, Rezaei M. The status of Linguatula serrata infection of stray dogs in Shiraz, Iran. Comp Clin Pathol. 2008;17:55–60. doi:10.1007/s00580-007-0707-x.
50. Rezaei F, Tavassoli M, Javdani M. Prevalence and morphological characterizations of Linguatula serrata nymphs in camels in Isfahan Province, Iran. Vet Res Forum. 2012;3:61–65.
51. Alborzi A, Molayan PH, Akbari M. Prevalence of Linguatula serrata nymphs in mesenteric lymph nodes of cattle and buffaloes slaughtered in Ahvaz abattoir, Iran. Iran J Parasitol. 2013;8:327–332.
52. Attia MM, et al. Prevalence of Linguatula serrata in herbivorous animals, Egypt. 2017 (as cited in regional reviews).
53. Islam R, Anisuzzaman, Hossain MS, et al. Linguatula serrata, a food-borne zoonotic parasite, in livestock in Bangladesh: some pathologic and epidemiologic aspects. 2018.
54. Prathap K, Lau KS, Bolton JM. Pentastomiasis: a common finding at autopsy among Malaysian aborigines. Am J Trop Med Hyg. 1969;18:20–27.
55. Smith JA, Oladiran B, Lagundoye SB. Pentastomiasis and malignancy. Ann Trop Med Parasitol. 1975;69:503–512.
56. Sulyok M, Rózsa L, Bodó I, Tappe D, Hardi R. Ocular pentastomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2014;8:e3041. doi:10.1371/journal.pntd.0003041.
57. Villedieu E, Sanchez RF, Jepson RE, Ter Haar G. Nasal infestation by Linguatula serrata in a dog in the UK: a case report. J Small Anim Pract. 2017;58:183–186.
58. Macrelli M, et al. Tongue worm (Linguatula serrata) infection in a dog imported into the United Kingdom from Romania. Vet Rec Case Rep. 2022. doi:10.1002/vrc2.281.
59. Globokar M, Pantchev N, Norden C, Kilo A. Linguatula serrata infestation in four imported dogs. Kleintierpraxis. 2005;50:779–784.
60. Nagamori Y, Ramachandran A, Kuzma C, Nafe L, Johnson EM. A zoonotic parasite, Linguatula serrata, infection in a dog imported from Ethiopia to the United States. Vet Parasitol X. 2019;1:100002.
61. Lavarde V, Fornes P. Lethal infection due to Armillifer armillatus (Porocephalida): a snake-related parasitic disease. Clin Infect Dis. 1999;29:1346–1347.
62. Watson JM, Kerim RA. Observations on forms of parasitic pharyngitis known as halzoun in the Middle East. J Trop Med Hyg. 1956;59:147–154.
63. Mehlhorn H, ed. Linguatula serrata. In: Encyclopedia of Parasitology. 3rd/4th ed. Heidelberg: Springer (species entry).
64. Sousaefaro B, Pinhão RC. An isolated case of ocular parasitosis caused by Linguatula serrata. J Soc Cienc Med Lisb. 1964;128:401–420.